Repeated dose toxicity: inhalation.001
Administrative data
- Study result type:
- experimental result
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed acording to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were exposed by 2 to 4 sessions of 15 minutes. Actual concentration in air was not determined. Urinalysis, clinical chemistry, ophthalmic and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- Action of a discontinuous exposure to chlorine dioxide (ClO2) on the rat
- Author:
- Paulet, G. and Desbrousses, S.
- Year:
- 1974
- Bibliographic source:
- Archives des Maladies Professionnelles, de Médecine du Travail et de Sécurité Sociale (Paris), 35(9):797-807
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Rats were exposed to chlorine dioxide in air (at 5, 10 or 15 ppm) for 2 to 4 session per day, for 1 month. Clinical signs were monitored daily. Body weights were determined. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.
- GLP compliance:
- no
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- No data
Test animals
- Species:
- rat
- Strain:
- no data
- Sex:
- no data
- Details on test animals and environmental conditions:
- No data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- no data
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic intoxication chamber
- Air flow rate: 15 L/min
No other information - Analytical verification of doses or concentrations:
- no data
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- Duration of treatment: 1 month
- Frequency of treatment:
- 15 minutes per session, 2 or 4 sessions per day
Doses / concentrationsopen allclose all
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 15 ppm ClO2, 2 exposures/day: 10 rats
15 ppm ClO2, 4 exposures/day: 15 rats
10 ppm ClO2, 2 exposures/day: 10 rats
10 ppm ClO2, 4 exposures/day: 10 rats
5 ppm ClO2, 2 exposures/day: 10 rats
5 ppm ClO2, 4 exposures/day: 10 rats - Control animals:
- yes, sham-exposed
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- CLINICAL SIGNS AND MORTALITY: Yes
- Time schedule: regularly
BODY WEIGHT: Yes
- Time schedule for examinations: regularly
FOOD CONSUMPTION: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: beginning and end of the study
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: all animals
- Parameters examined: red blood cell count, white blood cell count
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, viscera
HISTOPATHOLOGY: Yes, liver and lungs were examined in all animals
Organs were not weighted. - Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levelsopen allclose all
Results of examinations
- Clinical signs and mortality:
- yes
- Body weight and weight gain:
- yes
- Food consumption:
- not examined
- Food efficiency:
- not examined
- Water consumption:
- not examined
- Ophthalmoscopic examination:
- not examined
- Haematology:
- yes
- Clinical chemistry:
- not examined
- Urinalysis:
- not examined
- Neurobehaviour:
- not examined
- Organ weights:
- not examined
- Gross pathology:
- yes
- Histopathology: non-neoplastic:
- yes
- Histopathology: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY
15 ppm: animals have an ocular-nasal catarrh with excretion of mucous. No other adverse clinical signs were noted.
One death occurred in each 15 ppm dose groups.
BODY WEIGHT AND WEIGHT GAIN
Body weight gains were noted to be reduced in the 15 and 10 ppm dose groups.
HAEMATOLOGY (See Table 7.5.1/1)
Significant changes were not reported in the blood parameters in any dose group.
GROSS PATHOLOGY and HISTOPATHOLOGY
No effects were noted in the 5 ppm dose group.
10 ppm: the lung is the location of bronchitis and bronchiolitis characterised with signs of alveolar irritation, less marked than in the 15 ppm series.
15 ppm: the lungs were congested and a histological examination showed lesions of alveolitis with catarrh with peribronchiolar infiltrations more marked in the 4 exposure per day series; after ending of the exposures these lesions heal, and after 15 days, the condition of the lungs is comparable to that of the lungs of the control group. The liver appeared normal. - Any other information on results incl. tables:
- Table 7.5.3/1: Changes in blood cell counts in repeated dose toxicity studyParameterNumber of daily exposuresControl group (%)5 ppm (%)10 ppm (%)15 ppm (%)dose-response+/-Red blood cell count2-5+3+15+64+9+10+11+8White blood cell count2+17+27+4+124+20+32+7+15
Applicant's summary and conclusion
- Conclusions:
- The LOAEC in this study is 28 mg/m3 based on lung damage and the NOAEC is 14 mg/m3.
- Executive summary:
- In a subacute repeat-dose study, rats were exposed to Chlorine Dioxide by gas inhalation at dose level of 5, 10 or 15 ppm (14, 28 and 41 mg/m3), 15 minutes per session, 2 or 4 sessions per day, for one month. Control animals were sham-exposed.During the experiment period, rats were observed for clinical signs, mortality and haematology. At the end of the experiment, all dose group animals were sacrified and gross and histopathology were performed.One death occurred in the 15 ppm dose group. Animals in this group have an ocular-nasal catarrh with excretion of mucous.Body weight gains were noted to be reduced in the 15 and 10 ppm dose groups.Significant changes were not reported in the blood parameters in any dose group.Gross pathology and histopathology showed no effect of Chlorine Dioxide in 5 ppm dose group rats. In the 10 ppm dose group, the lung was the location of bronchitis and bronchiolitis characterised with signs of alveolar irritation, less marked than in the 15 ppm series. In the high dose group (15 ppm), the lungs were congested and a histological examination showed lesions of alveolitis with catarrh with peribronchiolar infiltrations more marked in the 4 exposure per day series. After ending of the exposures these lesions heal, and after 15 days, the condition of the lungs is comparable to that of the lungs of the control group. The liver appeared normal.Based on these observation, the LOAEC in this study is 28 mg/m3 and the NOAEC is 14 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Repeated dose toxicity: inhalation.002
Administrative data
- Purpose flag:
- supporting study
- Study result type:
- experimental result
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed according to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were only exposed 5 hours/d. No data on actual concentration in air. Clinical chemistry, haemathology, ophthalmoscopic examination, neurobehaviour and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- Chlorine dioxide - Toxicity in animal experiments and industrial risks.
- Author:
- Dalhamn T
- Year:
- 1957
- Bibliographic source:
- A.M.A. Archives of Industrial Health, 15: 101-107
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Ten rats were involved; five were controls and five were exposed 5 hours/day for ten weeks to approximately 0.1 ppm. Urine analysis, clincial observations and histology of the lungs, kidneys and liver were examined.
- GLP compliance:
- no data
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- chlorine dioxide gas (purity and batch number not stated)
Test animals
- Species:
- rat
- Strain:
- no data
- Sex:
- no data
- Details on test animals and environmental conditions:
- Source: no data
Age: no data
Weight at study initiation: no data
Food consumption: no data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- no data
- Vehicle:
- other: gas
- Details on inhalation exposure:
- Compressed air and ClO2 gas ( the latter via air bubbled through a solution of ClO2) were mixed in a mixing chamber. After passing through the exposure chamber, ClO2 gas was allowed to escape either through a fume cupboard or through a Peligot tube containing KI solution and via a drying tower through a gas meter (when the mixture was sampled).
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 10 weeks
- Frequency of treatment:
- 5 hours/day
Doses / concentrations
- Doses / concentrations:
- 0 and 0.1 ppm (0 and 0.28 mg/m3)
- Basis:
- nominal conc.
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 5 rats/dose
- Control animals:
- yes
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- Behavioural observations and weight (frequency unstated)
- Sacrifice and pathology:
- Organs examined at necropsy: kidney, liver and lungs
- Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levels
- Endpoint:
- NOEC
- Effect level:
- 0.28 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- no data
Results of examinations
- Clinical signs and mortality:
- no effects
- Body weight and weight gain:
- no effects
- Food consumption:
- no data
- Food efficiency:
- no data
- Water consumption:
- no data
- Ophthalmoscopic examination:
- no data
- Haematology:
- no data
- Clinical chemistry:
- no data
- Urinalysis:
- no data
- Neurobehaviour:
- no data
- Organ weights:
- no data
- Gross pathology:
- no data
- Histopathology: non-neoplastic:
- no data
- Histopathology: neoplastic:
- no data
- Details on results:
- During the period of exposure, the rats were not noticeably affected, nor did their weight curve differ from that of the controls. Histologic examination revealed normal kidneys, liver and lungs in the exposed rats.
- Any other information on results incl. tables:
- No data
Applicant's summary and conclusion
- Conclusions:
- In this study, the NOEC was defined as 0.28 mg/m3.
- Executive summary:
- In a subchronic study, rats were exposed to Chlorine Dioxide by gas inhalation, at dose level of 0.1 ppm (0.28 mg/m3), for five hours, once a day, for ten weeks.Ten rats were involved; five were controls and five were exposed to test substance. Urine analysis and clinical observations were performed and histology of the lungs, kidneys and liver were examined.During the period of exposure, the rats were not noticeably affected, nor did their weight curve differ from that of the controls. Histologic examination revealed normal kidneys, liver and lungs in the exposed rats.In this study, the NOEC was defined as 0.28 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information
Repeated dose toxicity: inhalation.003
Administrative data
- Purpose flag:
- weight of evidence
- Study result type:
- experimental result
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed according to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were only exposed 5 hours/d. No data on actual concentration in air. Urinalysis, clinical chemistry, ophthalmic and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- On the toxicology of ClO2
- Author:
- Paulet, G and Desbrousses, D
- Year:
- 1971
- Bibliographic source:
- Société de Médecine et d’Hygiene du Travail, Séance du 11 October 1971.
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Rats were exposed to chlorine dioxide in air (at 1 ppm) for 5 hours per day, 5 days per week for 2 months. Clinical signs were monitored daily. Body weights were determined weekly. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.
- GLP compliance:
- no
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- No data
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- no data
- Details on test animals and environmental conditions:
- No data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: air
- Details on inhalation exposure:
- No data
- Analytical verification of doses or concentrations:
- no data
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 2 months
- Frequency of treatment:
- 5 hours per day, 5 days per week
Doses / concentrations
- Doses / concentrations:
- 0 and 1 ppm (0 and 2.8 mg/m3)
- Basis:
- nominal conc.
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 8 rats/dose
- Control animals:
- yes, sham-exposed
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- CLINICAL SIGNS AND MORTALITY: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: beginning and end of the study
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: all animals
- Parameters examined: red blood cell count, white blood cell count
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, viscera
HISTOPATHOLOGY: Yes, liver and lungs were examined in all animals
Organs were not weighted. - Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levelsopen allclose all
Results of examinations
- Clinical signs and mortality:
- no effects
- Body weight and weight gain:
- no effects
- Food consumption:
- not examined
- Food efficiency:
- not examined
- Water consumption:
- not examined
- Ophthalmoscopic examination:
- not examined
- Haematology:
- no effects
- Clinical chemistry:
- not examined
- Urinalysis:
- not examined
- Neurobehaviour:
- not examined
- Organ weights:
- not examined
- Gross pathology:
- yes
- Histopathology: non-neoplastic:
- yes
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No effects or mortality observed.
BODY WEIGHT AND WEIGHT GAIN
No effects observed.
HAEMATOLOGY
No effects observed.
GROSS PATHOLOGY and HISTOPATHOLOGY
It was observed on all of the lungs, whatever the duration of the experiment, a congestion of the vessels of all calibres and very small lesions of interstitial oedema afflicting the bronchial mucous membranes and the walls of the bronchi, without perceptibly altering the epithelium. The pulmonary parenchyma on the other hand is absolutely normal. Wilder and orcein stains show that the reticular and elastic structures of the alveoli, the vessels and the bronchi are intact. - Any other information on results incl. tables:
- No data
Applicant's summary and conclusion
- Conclusions:
- Based on respiratory effects, the LOAEC in this study is 2.8 mg/m3.
- Executive summary:
- In a subchronic study, Wistar rats were exposed to Chlorine Dioxide by gas inhalation, at dose level of 1ppm (2.8mg/m3), for 5 hours per day, 5 days per week, for 2 months. Control animals were sham-exposed.Clinical signs were monitored daily. Body weights were determined weekly. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.No clinical signs due to Chlorine Dioxide or mortalities were observed. No body weight changes or haematologic effects were observed.It was observed on all of the lungs, whatever the duration of the experiment, a congestion of the vessels of all calibres and very small lesions of interstitial oedema afflicting the bronchial mucous membranes and the walls of the bronchi, without perceptibly altering the epithelium. The pulmonary parenchyma on the other hand is absolutely normal. Wilder and orcein stains show that the reticular and elastic structures of the alveoli, the vessels and the bronchi are intact.Based on these observation, the LOAEC in this study is 2.8 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the informatio
Reproduction or further distribution of this information may be subject to copyright protection. Use of the informatio
Repeated dose toxicity: inhalation.004
Administrative data
- Purpose flag:
- weight of evidence
- Study result type:
- experimental result
- Study period:
- No data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed according to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were only exposed 2 hours for the two upper concentrations tested. Urinalysis, clinical chemistry, ophthalmic and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- On the action of chlorine dioxide (ClO2) at low concentrations on laboratory animals
- Author:
- Paulet, G and Desbrousses, S
- Year:
- 1970
- Bibliographic source:
- Archives des Maladies Professionnelles, de Médecine du Travail et de Sécurité Sociale (Paris), 81(3): 97-106
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of male and female rats were exposed to chlorine dioxide in air (at 10, 5 or 2.5 ppm) daily for 2 or 4-7 hours per day for 30 days. Clinical signs were monitored daily. Body weights were determined weekly. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.
- GLP compliance:
- no
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- Chlorine dioxide was generated in solution by reacting an acid with sodium chlorite. The chlorine dioxide was removed from the solution by passing a current of air through the solution. The apparatus is capable of producing chlorine dioxide concentrations in air of between 2.5 and 13 ppm with a precision of +/- . %
Test animals
- Species:
- rat
- Strain:
- no data
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age: one month old at study initiation
- Weight: 61-64 g (group averages for rats) at study initiation
No other information
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic intoxication chamber in plexiglas
No other information - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- During exposure of the animals, samples of the atmosphere were taken to test the concentration of chlorine dioxide present, although the analytical method and results are not stated.
- Duration of treatment / exposure:
- 30 days
- Frequency of treatment:
- 5 and 10 ppm: 2 hours per day, daily. 2.5 ppm: 7 hours per day, daily
Doses / concentrations
- Doses / concentrations:
- 0; 2.5; 5 and 10 ppm (0; 6.9; 14 and 28 mg/m3)
- Basis:
- nominal conc.
- MMAD / GSD:
- Not applicable
- No. of animals per sex per dose:
- 10 ppm: 5 rats/sex/group; controls 5 rats/sex/group
5 ppm: 2*5 rats/sex/group; controls 2*5 rats/sex/group
2.5 ppm (30 days): 10 rats/sex/group - Control animals:
- yes, sham-exposed
- Details on study design:
- Post exposure period: 15 days
- Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- CLINICAL SIGNS AND MORTALITY: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: beginning and end of the study
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: all animals
- Parameters examined: red blood cell count, white blood cell count, neutrophil, eosinophil, basophile, lymphocytes, monocytes
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, viscera
HISTOPATHOLOGY: Yes, liver and lungs were examined in all animals
Organs were not weighted. - Other examinations:
- Not done
- Statistics:
- Not done
Results and discussion
Effect levelsopen allclose all
Results of examinations
- Clinical signs and mortality:
- yes
- Body weight and weight gain:
- yes
- Food consumption:
- not examined
- Food efficiency:
- not examined
- Water consumption:
- not examined
- Ophthalmoscopic examination:
- not examined
- Haematology:
- yes
- Clinical chemistry:
- not examined
- Urinalysis:
- not examined
- Neurobehaviour:
- not examined
- Organ weights:
- not examined
- Gross pathology:
- no effects
- Histopathology: non-neoplastic:
- yes
- Histopathology: neoplastic:
- no effects
- Details on results:
- CLINICAL SIGNS AND MORTALITY
10 ppm: Mucopurulent nasal secretions in exposed animals, irritation of the mucous membrane of the nose. Red eyes especially at the end of exposure.
5 ppm: Slight eye irritation, transitory
2.5 ppm: Normal appearance.
No mortalities at any dose level
BODY WEIGHT AND WEIGHT GAIN (See table 7.5.3/1)
10 ppm: Slight decrease in body weight gain observed.
5 ppm: Normal growth
2.5 ppm: Clear decrease in growth rate.
HAEMATOLOGY (See table 7.5.3/2)
10 ppm: Red blood cell count increased by 40 %. White blood cells count increased by 95 %. No changes in eosinophil, basophile, lymphocyte and monocyte counts.
5 ppm: No change in red blood cell count. White blood cell count increased by 40-50 %. No changes in blood cell differentiation.
2.5 ppm: Blood count remained normal.
GROSS PATHOLOGY and HISTOPATHOLOGY
10 ppm: No macroscopic abnormalities of the internal organs. Some bronchoalveolar lesions: multifocal non-infectuous bronchopneumonia, histologically the affected areas of the lung were mainly peri-vascular and showed alveoli filled with cellular debris from desquamated alveolar epithium.
5 ppm: Histologically the same lesions as at 10 ppm, but less pronounced. Liver not affected
2.5 ppm: Alveolar cavities infiltrated with polynuclear cells and macrophages, vascular congestion. Thickening of Interalveolar septa. Focal haemorrhagic alveolitis. Small epithelial erosions and inflammtory infiltrates in some of the larger bronchi. Recovery from the pulmonary lesions was apparent in rats examined after a 15-day recovery period. - Any other information on results incl. tables:
- Table 7.5.3/1: Average body weights (males and females)Body Weights (g)Dose rate (ppm)Study initiationWeek 1Week 2Week 3Week 40931211491752075 (A)86124136174184079921121211385 (B)69821021111250618610512414910648093115131Table 7.5.3/2: Haematology findingsParameter2.5ppm5ppm (A)5 ppm (B)10ppmInitialFinalInitialFinalInitialFinalInitialFinalRed blood cell count (103/mm3)7818661451325036No change50126998- 16 %No change+ 40 %White blood cell count26180302601566023860+ 40 %899017580+ 16 %+ 52 %+ 95 %Neutrophil24.618.425.82218.1206- 25 %- 15 %+ 1040 %Eosinophil1.22.6111.81.4+ 116 %=- 23 %Basophil0.40.2000.20.4- 50 %=+ 100 %Lymphocytes70.87670.273.47774.3+ 7.3 %+ 4.5 %- 3.5 %Monocytes32.833.62.93.3
Applicant's summary and conclusion
- Conclusions:
- Based on respiratory effects, the LOAEC in this study is 6.9 mg/m3, the lowest concentration tested.
- Executive summary:
- In subacute repeat-dose study, rats (10/sex/group) were exposed to Chlorine Dioxide (ClO2) vapors at concentrations of 2.5 ppm 7 h/day or 5 and 10 ppm, 2 h/day, daily, for 30 days (corresponding to nominal concentrations of 6.9; 14 and 28 mg/m3).Clinical signs were monitored daily, body weights were determined weekly and blood analyses were performed at the beginning and the end of the tests. All surviving animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.No mortality was observed, at any dose level.Clinical signs observed were as follow: at 10 ppm dose level, mucopurulent nasal secretion and conjunctival irritation; at 5 ppm dose level, minor eye irritation and at 2.5 ppm dose level, no effects.A slight and a clear decrease in growth rate were observed at 10 ppm and 2.5 ppm dose levels respectively whereas the animals show normal growth. at 5 ppm dose level.At 10 ppm, red blood cell count increased by 40 % and white blood cells count increased by 95 %. No changes in eosinophil, basophile, lymphocyte and monocyte counts was noted. At 5 ppm, there was no change in red blood cell count while white blood cell count increased by 40-50 %. No changes in blood cell differentiation was noted. At 2.5 ppm, blood count remained normal.No macroscopic abnormalities of the internal organs were observed at 10 ppm and 5 ppm dose level. Multifocal non-infectuous broncho pneumonia were observed at 10 ppm dose level and histologically, the affected areas of the lung were mainly peri-vascular and showed alveoli filled with cellular debris from desquamated alveolar epithium. The same histological lesions were obersed at 5 ppm dose level, but less pronounced.At 2.5 ppm dose level, alveolar cavities were infiltrated with polynuclear cells and macrophages and vascular congestion was observed. Thickening of Interalveolar septa, focal haemorrhagic alveolitis, small epithelial erosions and inflammtory infiltrates in some of the larger bronchi were also observed. Recovery from the pulmonary lesions was apparent in rats examined after a 15-day recovery period.Based on respiratory effects, the LOAEC in this study is 6.9 mg/m3, the lowest concentration tested.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective
Repeated dose toxicity: inhalation.005
Administrative data
- Study result type:
- experimental result
- Study period:
- No data
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- Does not meet important criteria of today standard methods.
Data source
Reference
- Reference Type:
- publication
- Title:
- Chlorine dioxide - Toxicity in animal experiments and industrial risks.
- Author:
- Dalhamn, T.
- Year:
- 1957
- Bibliographic source:
- A.M.A. Archives of Industrial Health. 3:451-460
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Six rats were used, three of which were controls and three exposed once a week for three weeks for three minutes to either 800, 1100 or 3400 ppm.
- GLP compliance:
- no data
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- Chlorine dioxide gas (purity and batch number not stated)
Test animals
- Species:
- rat
- Strain:
- no data
- Sex:
- no data
- Details on test animals and environmental conditions:
- Source: no data
Age: no data
Weight at study initiation: 268 g
Food consumption: no data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- no data
- Vehicle:
- other: gas
- Details on inhalation exposure:
- Compressed air and ClO2 gas (the latter via air bubbled through a solution of ClO2) were mixed in a mixing chamber. After passing through the exposure chamber, ClO2 gas was allowed to escape either through a fume cupboard or through a Peligot tube containing IKI solution and via a drying tower through a gas meter.
- Analytical verification of doses or concentrations:
- no data
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 3 minute exposure
- Frequency of treatment:
- Once a week for three weeks
Doses / concentrations
- Doses / concentrations:
- 800, 1100 or 3400 ppm
- Basis:
- nominal conc.
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 3 animals in total (sex not stated)
- Control animals:
- yes
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- Clinical observations performed: respiration and weight (frequency unstated)
- Sacrifice and pathology:
- Organs examined at necropsy: kidneys, lungs, liver
- Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levels
- Endpoint:
- LOAEL
- Effect level:
- >= 800 - <= 3 400 ppm
- Based on:
- test mat.
- Sex:
- no data
Results of examinations
- Clinical signs and mortality:
- yes
- Body weight and weight gain:
- yes
- Food consumption:
- no data
- Food efficiency:
- no data
- Water consumption:
- no data
- Ophthalmoscopic examination:
- no data
- Haematology:
- no data
- Clinical chemistry:
- no data
- Urinalysis:
- no data
- Neurobehaviour:
- no data
- Organ weights:
- no data
- Gross pathology:
- no data
- Histopathology: non-neoplastic:
- yes
- Histopathology: neoplastic:
- no data
- Details on results:
- Effects noted included respiratory distress in the form of rhinorrhea and embarassed respiration and decreased body weight. Histopathological examination showed small areas of recent bronchopneumonia and hyperemia of the renal corticomedullary junction in two of the exposed rats. The lungs and kidneys of the third exposed rat were normal.
- Any other information on results incl. tables:
- No data
Applicant's summary and conclusion
- Conclusions:
- LOAEL was defined as ≥ 800 ppm and ≤ 3400 ppm.
- Executive summary:
- In a subacute study, rats were exposed to Chlorine Dioxide by gas inhalation, at dose levels of 800, 1100 or 3400 ppm, for three minutes, once a week, for three weeks. Six rats were used, three of which were controls and three were exposed to test substance. Animals were observed for respiration and weight changes. At the end of the experiment, animals were sacrified and kidneys, lungs and liver were examined.Effects noted included respiratory distress in the form of rhinorrhea and embarassed respiration and decreased body weight. Histopathological examination showed small areas of recent bronchopneumonia and hyperemia of the renal corticomedullary junction in two of the exposed rats. The lungs and kidneys of the third exposed rat were normal.Evidence of renal effects in animals is limited to two of three rat; however, two of three control rats similarly exhibited renal hyperemia.LOAEL was defined as ≥ 800 ppm and ≤ 3400 ppm.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the inform
Reproduction or further distribution of this information may be subject to copyright protection. Use of the inform
Repeated dose toxicity: inhalation.006
Administrative data
- Purpose flag:
- weight of evidence
- Study result type:
- experimental result
- Study period:
- No data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed according to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were only exposed 2 hours and 4 hours. Urinalysis, clinical chemistry, ophthalmic and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- On the action of chlorine dioxide (ClO2) at low concentrations on laboratory animals
- Author:
- Paulet G and Desbrousses S
- Year:
- 1970
- Bibliographic source:
- Archives des Maladies Professionnelles, de Médecine du Travail et de Sécurité Sociale (Paris), 81(3): 97-106
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of rabbits were exposed to chlorine dioxide in air (at 5 or 2.5 ppm) daily for 2 or 4 hours per day for 30 or 45 days. Clinical signs were monitored daily. Body weights were determined weekly. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.
- GLP compliance:
- no
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- Chlorine dioxide was generated in solution by reacting an acid with sodium chlorite. The chlorine dioxide was removed from the solution by passing a current of air through the solution. The apparatus is capable of producing chlorine dioxide concentrations in air of between 2.5 and 13 mg/L.
Test animals
- Species:
- rabbit
- Strain:
- no data
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
Age: rabbits described as “young animals”
Weight: 679 – 708 g (group averages for rabbits)
No other data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic intoxication chamber in plexiglas
No other information - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- During exposure of the animals, samples of the atmosphere were taken to test the concentration of chlorine dioxide present, although the analytical method and results are not stated.
- Duration of treatment / exposure:
- Duration of treatment: 30 days (5 ppm), 45 days (2.5 ppm)
- Frequency of treatment:
- 5 ppm: 2 hours per day, daily.2.5 ppm: 4 hours per day, daily
Doses / concentrations
- Doses / concentrations:
- 0; 2.5 and 5 ppm (0; 6.9 and 14 mg/m3)
- Basis:
- nominal conc.
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 5 ppm: 4 rabbits; controls: 5 rabbits
2.5 ppm: 8 rabbits; controls: 7 rabbits - Control animals:
- yes, sham-exposed
- Details on study design:
- Post exposure period: 15 days
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- CLINICAL SIGNS AND MORTALITY: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: beginning and end of the study
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: all animals
- Parameters examined: red blood cell count, white blood cell count, neutrophil, eosinophil, basophile, lymphocytes, monocytes
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, viscera
HISTOPATHOLOGY: Yes, liver and lungs were examined in all animals
Organs were not weighted. - Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levelsopen allclose all
Results of examinations
- Clinical signs and mortality:
- yes
- Body weight and weight gain:
- yes
- Food consumption:
- not examined
- Food efficiency:
- not examined
- Water consumption:
- not examined
- Ophthalmoscopic examination:
- not examined
- Haematology:
- yes
- Clinical chemistry:
- not examined
- Urinalysis:
- not examined
- Neurobehaviour:
- not examined
- Organ weights:
- not examined
- Gross pathology:
- no effects
- Histopathology: non-neoplastic:
- yes
- Histopathology: neoplastic:
- no effects
- Details on results:
- CLINICAL SIGNS AND MORTALITY
5 ppm: Wet nasal secretions in exposed animals
2.5 ppm: Normal appearance.
No mortalities at any dose level
BODY WEIGHT AND WEIGHT GAIN (See table 7.5.3/1)
5 ppm: Slight decrease in body weight gain observed from the second weeks of treatment.
2.5 ppm: Minor decrease in growth rate was observed during the second week.
HAEMATOLOGY (See table 7.5.3/2)
5 ppm: No change in red blood cell count. White blood cell count increased by 59 %. No changes in blood cell differentiation.
2.5 ppm: Blood count remained normal.
GROSS PATHOLOGY and HISTOPATHOLOGY
5 ppm: No macroscopic abnormalities of the internal organs. Some bronchoalveolar lesions.
2.5 ppm: No macroscopic lesions of internal organs. Lungs showed small foci of haemorrhagic alveolitis with alveolar vascular congestion. Recovery from the pulmonary lesions was apparent in rats examined after a 15-day recovery period. - Any other information on results incl. tables:
- Table 7.5.3/1: Average body weightsBody Weights (g)Dose rate (ppm)Study initiationWeek 1Week 2Week 3Week 407088831004124214125679854101011091260Table 7.5.3/2: Haematology findingsParameter2.5ppm5ppmInitialFinalInitialFinalRed blood cell count (103/mm3)4629373246434470- 20 %- 4.1 %White blood cell count1540016250780011433+ 5.5 %+ 59 %Neutrophil47.3347.33=Eosinophil1.331.66+ 25 %Basophil1.331- 25 %Lymphocytes42.3346+ 8.7 %Monocytes7.664- 48 %
Applicant's summary and conclusion
- Conclusions:
- Based on these observation, the LOAEC in this study is 6.9 mg/m3, the lowest concentration tested.
- Executive summary:
- In a subacute repeat-dose toxicity study, groups of young rabbits were exposed to Chlorine Dioxide (ClO2) vapors at concentrations of 2.5 ppm (6.9 mg/m3), 2 h/day, daily, for 45 days, or at dose level of 5 ppm (14 mg/m3), 4 h/day, daily, for 30 days.Clinical signs were monitored daily. Body weights were determined weekly. Blood analyses were performed at the beginning and the end of the tests. All animals were sacrificed at study termination and subjected to histopathological analysis of the lungs and liver.No mortalities were observed at any dose level.At 5 ppm, wet nasal secretions were noted.A slight decrease in body weight gain was observed from the second weeks of treatment with 5 ppm and minor decrease in growth rate was noted at 2.5 ppm.At 5 ppm, white blood cell count increased by 59 %. There was no changes in blood cell differentiation and in red blood cell count.At 2.5 ppm, blood count remained normal.No macroscopic abnormalities of the internal organs. Some bronchoalveolar lesions were observed at 5 ppm. Lungs of 2.5 ppm exposed group showed small foci of haemorrhagic alveolitis with alveolar vascular congestion. Recovery from the pulmonary lesions was apparent in rats examined after a 15-day recovery period.Based on these observation, the LOAEC in this study is 6.9 mg/m3, the lowest concentration tested.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective
Repeated dose toxicity: inhalation.007
Administrative data
- Purpose flag:
- supporting study
- Study result type:
- experimental result
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- Study not performed according to a guideline and not GLP. No details concerning material and method and few details on results are available. Animals were only exposed 4 hours/d. No data on actual concentration in air. Clinical chemistry, haemathology, ophthalmoscopic examination, neurobehaviour and food and water analyses were not performed. Statistical analysis is not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- Chlorine dioxide - Toxicity in animal experiments and industrial risks.
- Author:
- Dalhamn, T
- Year:
- 1957
- Bibliographic source:
- A.M.A. Archives of Industrial Health. 15: 101-107
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Ten rats were involved; five were controls and five exposed once a day for 4 hours/day for 9 days in a 13-day period to approximately 10 ppm.
- GLP compliance:
- no
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
- Details on test material:
- chlorine dioxide gas (purity and batch number not stated)
Test animals
- Species:
- rat
- Strain:
- no data
- Sex:
- no data
- Details on test animals and environmental conditions:
- No data
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- no data
- Vehicle:
- other: gas
- Details on inhalation exposure:
- Compressed air and ClO2 gas ( the latter via air bubbled through a solution of ClO2) were mixed in a mixing chamber. After passing through the exposure chamber, ClO2 gas was allowed to escape either through a fume cupboard or through a Peligot tube containing KI solution and via a drying tower through a gas meter (when the mixture was sampled).
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 9 days
- Frequency of treatment:
- 4 hours/day for 9 days in a 13-day period
Doses / concentrations
- Doses / concentrations:
- 0 and 10 ppm (0 and 28 mg/m3)
- Basis:
- nominal conc.
- MMAD / GSD:
- No data
- No. of animals per sex per dose:
- 5 rats/dose
- Control animals:
- yes, sham-exposed
- Details on study design:
- No data
- Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- Urine was examined for protein, and the weight of the rats was charted.
- Sacrifice and pathology:
- No data
- Other examinations:
- No data
- Statistics:
- No data
Results and discussion
Effect levels
- Endpoint:
- LOAEC
- Effect level:
- 28 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- no data
- Basis for effect level / Remarks:
- rhinorrhea and embarrased respiration
Results of examinations
- Clinical signs and mortality:
- yes
- Remarks:
- One rat died after 10 days' exposure, and two died after a further day. The two remaining rats died on the 13th day
- Body weight and weight gain:
- yes
- Food consumption:
- no data
- Food efficiency:
- no data
- Water consumption:
- no data
- Ophthalmoscopic examination:
- no data
- Haematology:
- no data
- Clinical chemistry:
- no data
- Urinalysis:
- no data
- Neurobehaviour:
- no data
- Organ weights:
- no data
- Gross pathology:
- no data
- Histopathology: non-neoplastic:
- yes
- Remarks:
- acute renal and hepatic congestion
- Histopathology: neoplastic:
- no data
- Details on results:
- The exposed rats showed marked distress in the form of rhinorrhea and embarrassed respiration. The number of positive urinary protein tests was not greater in the exposed rats than in the controls. The weight of the exposed rats, however, showed a mean reduction of about 80 gm, while that of the controls was largely unaltered. One rat died after 10 days' exposure, and two died after a further day. The two remaining rats died on the 13th day. The kidneys, liver, and lungs were examined. In all the exposed rats microscopy showed changed resulting from respiratory infection with acute renal and hepatic congestion. Nothing of note was seen in the control rats.
- Any other information on results incl. tables:
- No data
Applicant's summary and conclusion
- Conclusions:
- The LOAEC in this study is 28 mg/m3, based on respiratory effects.
- Executive summary:
- In a subacute study, rats (5 per group) were exposed to Chlorine Dioxide by gas inhalation at dose level of 0 and 10 ppm (0 and 28 mg/m3), 4 h/d for 9 days in a 13 -day period.Urine was examined for protein, and the weight of the rats was charted. At the end of the experiment, animals were sacrified and kidneys, liver and lungs were examined at necropsy.The exposed rats showed marked distress in the form of rhinorrhea and embarrassed respiration.The number of positive urinary protein tests was not greater in the exposed rats than in the controls.The weight of the exposed rats, however, showed a mean reduction of about 80 mg, while that of the controls was largely unaltered.One rat died after 10 days' exposure, and two died after a further day. The two remaining rats died on the 13th day.The kidneys, liver, and lungs were examined. In all the exposed rats microscopy showed changed resulting from respiratory infection with acute renal and hepatic congestion.The LOAEC in this study is 28 mg/m3, based on respiratory effects.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee
Repeated dose toxicity: inhalation-008
Administrative data
- Study result type:
- experimental result
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- No details on test substance preparation in the air disinfector.
Comparable to guideline study with acceptable restrictions: 2 hours exposure per day only, no details on exposure apparatus.
Data source
Reference
- Reference Type:
- publication
- Title:
- Study on the subacute toxicity of chlorine dioxide gas
- Author:
- Yang,G.-G.; Xie, J.-Q.; Yang, M.-L. and Hu Y.-C.
- Year:
- 2009
- Bibliographic source:
- Chinese Journal of Disinfection, 26(2):137-140
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to
- Guideline:
- OECD Guideline 412 (Repeated Dose Inhalation Toxicity: 28/14-Day)
- Deviations:
- yes
- Remarks:
- 2 hours exposure per day only, no details on exposure apparatus.
- Principles of method if other than guideline:
- Study of the cumulative toxicity and target organs of repetitive inhalation exposure to chlorine dioxide.
- GLP compliance:
- no data
- Test type:
- subacute
- Limit test:
- no
Test materials
- Identity of test material same as for substance defined in section 1 (if not read-across):
- yes
Test material identityopen allclose all
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Laboratory Animal Center of Southern Medical University
- Age at study initiation:
- Weight at study initiation: 145-182 g
- Fasting period before study:
- Housing:
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Chlorine dioxide was produced using an air disinfector (provided by APKS Environmental Technology, Foshan, Guangdong). The test was conducted in a testing cabinet measuring 1 m3. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Before the test, actual chlorine concentrations were measured and adjusted to ensure complete match with the designed dosage.
- Duration of treatment / exposure:
- 2 hours per day for 30 days
- Frequency of treatment:
- daily
Doses / concentrations
- Doses / concentrations:
- 22.5, 45 and 90 mg/m3
- Basis:
- analytical conc.
- MMAD / GSD:
- no data
- No. of animals per sex per dose:
- 10 rats/sex/dose
- Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale:
- Rationale for animal assignment: random
- Rationale for selecting satellite groups:
- Post-exposure recovery period in satellite groups: - Positive control:
- no data
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations included: typical physiological signs, appearance, behavior pattern, urination and defecation, eyes and fur
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: No
FOOD EFFICIENCY: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: No data
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: all
- Parameters checked in table 7.5.3/1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: No data
- Animals fasted: No data
- How many animals: all
- Parameters checked in table 7.5.3/1 were examined.
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- Internal organs were weighted and organ/body weight ratio was calculated.
GROSS PATHOLOGY: Yes: liver, kidney, windpipe, lungs, stomach, small intestine and sex gland...
HISTOPATHOLOGY: Yes: liver, kidney, windpipe, lungs, stomach, small intestine (high-dose and control group animals) - Other examinations:
- no
- Statistics:
- no data
Results and discussion
Effect levels
- Endpoint:
- NOAEL
- Effect level:
- 90 mg/m³ air
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level / Remarks:
- no effect observed
Results of examinations
- Clinical signs and mortality:
- no effects
- Body weight and weight gain:
- no effects
- Food consumption:
- not examined
- Food efficiency:
- not examined
- Water consumption:
- not examined
- Ophthalmoscopic examination:
- not examined
- Haematology:
- no effects
- Clinical chemistry:
- no effects
- Urinalysis:
- not examined
- Neurobehaviour:
- not examined
- Organ weights:
- no effects
- Gross pathology:
- no effects
- Histopathology: non-neoplastic:
- no effects
- Histopathology: neoplastic:
- no effects
- Details on results:
- HAEMATOLOGY
The number of WBC of male rats in the medium-dosage group and the number of RBC in the high-dose group are significantly higher (P > 0.05) than that found in rats in the negative control group. Nevertherless, differences found in both cases fell within the historical reference range of the laboratory. No other abnormalities were found.
See Table 7.5.3/2.
CLINICAL CHEMISTRY
Significant differences (P<0.05) in blood sugar and total protein were found between male rats of dose groups and those of the control group,and in ALT, total protein, albumin and blood sugar between dosed and undosed females. Nevertheles, differences found in both cases fell with the historical reference range .
See Table 7.5.3/3. - Any other information on results incl. tables:
- Table 7.5.3/2: Routine blood test markersDosage (mg/m3)RBC count (1012/L)WBC count (109/L)Male07.17 ± 0.2012.2 ± 2.522.57.05 ± 0.2812.7 ± 1.9457.14 ± 0.2615.7 ± 3.2*907.38 ± 0.18*15.1 ± 2.3Female07.20 ± 0.3311.6 ± 3.622.57.15 ± 0.2710.8 ± 2.4457.18 ± 0.2812.5 ± 3.0907.09 ± 0.2014.4 ± 2.3* Statistically significant (P<0.05)Table 7.5.3/3: Serum biochemical markersDosage (mg/m3)Glucose (mmol/L)Total cholesterol (mmol/L)ALT (U/L)Total protein (g/L)Albumin (g/L)Male05.55 ± 1.121.25 ± 0.1437.1 ± 8.657.4 ± 2.028.0 ± 1.122.54.89 ± 0.451.32 ± 0.2038.6 ± 5.057.1 ± 2.627.8 ± 1.6454.37 ± 1.04*1.40 ± 0.1440.3 ± 6.159.0 ± 2.628.6 ± 1.2904.50 ± 0.691.53 ± 0.16*37.0 ± 7.558.8 ± 2.429.1 ± 1.1Female04.16 ± 0.721.41 ± 0.2533.1 ± 3.663.6 ± 1.731.8 ± 1.122.54.51 ± 0.511.31 ± 0.1330.3 ± 4.160.6 ± 2.2*30.1 ± 1.1*454.73 ± 0.401.39 ± 0.1629.0 ± 3.260.3 ± 3.229.7 ± 2.1905.00 ± 0.67*1.46 ± 0.2127.9 ± 2.8*61.0 ± 2.1*30.8 ± 1.4* Statistically different (P<0.05)
Applicant's summary and conclusion
- Conclusions:
- The no observed adverse effect level (NOAEL) is over 90.0 mg/m3 (2h) in this study. No LOAEL was determined and no main target organ was observed.
- Executive summary:
- In a sub-acute study conducted similarly to OECD test guideline No. 412 (1981), Chlorine dioxide gas was administered to Wistar rats (10/sex/group) at 22.5, 45 or 90 mg/m3, 2 hours per day, for 30 days. The remaining group served as the negative control group.Hematological indexes and organ indexes were examined to determine the inhalation toxicity.Under condition of continuous inhalation of the highest dose 90 mg/m3, no abnormality in physiological sign, behavior pattern, urination and defecation, and fur was found. The changes of body weight, organ weight, organ/body weight ratio, hematological and biochemical indexes were in normal ranges. No abnormality was found in gross necropsy and histological examination of various preserved organs.The no observed adverse effect level (NOAEL) is over 90.0 mg/m3 (2h) in this study. No LOAEL was determined and no main target organ was observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This informat
that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by
information might violate the rights of the owner.
ation without obtaining the permission from the owner(s) of the respective information might
violate the rights of the owner.
information might violate the rights of the owner.
n without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Keine Kommentare:
Kommentar veröffentlichen